Urinary Iodine Concentration in a Cohort of Adult Outpatients with Thyroid Diseases in Liguria 14 Years after the Law on Salt Iodization.

Italy is considered a mildly iodine-deficient country. The aim of this study was to evaluate the iodine status of a cohort of adults living in Liguria after the 2005 salt iodization program. We searched all medical records of patients examined in two endocrine outpatient clinics in Genoa and Savona for data on urinary iodine.

[Carcinoid of Vater's papilla. The authors' own experience].

Carcinoid tumours of the papilla of Vater, like all those of the gastroenteric tract, belong to the PUD system: in fact they excrete different amines and polypeptidic hormones that cause articulated and complex clinical features. We describe the clinical picture of a non secreting carcinoid tumour in a patient suffering from cholelithiasis in who jaundice has appeared after video-laparocholecystectomy; ERCP detected a papillary neoplasia which proved to be a carcinoid tumour at immunohistochemical investigation. The patient was submitted to surgical removal of the neoplasia by the trans-duodenal way.

Results of rebiopsy for suspected prostate cancer in symptomatic men with elevated PSA levels.

Aim Of The Study: To develop indications for repeat biopsy in patients with suspected prostate cancer and first negative biopsy.

Materials And Methods: 148 consecutive patients, submitted to two or more biopsies for suspected prostate cancer, were extracted from our database on prostatic diseases. Patients were stratified according to the results of the last biopsy (benign or carcinoma) considering the results of the first and of the last biopsy when more than two biopsies had been performed.

Procollagen type I carboxyterminal extension peptide in serum: a reliable marker of bone metastatic disease in newly diagnosed prostate cancer?

Objective: This study evaluates the accuracy of type I procollagen, a bone matrix glycoprotein, and prostate-specific antigen (PSA) as markers for predicting the results of radionuclide bone scan in newly diagnosed, previously untreated patients with prostate cancer.

Methods: 74 patients underwent serum PSA and procollagen determination using specific antibodies. A staging radionuclide bone scan was then performed; patients with positive bone scan were submitted to x-rays of the suspicious zones.

Comparison between digital rectal examination, prostate-specific antigen and transrectal ultrasound in symptomatic patients. Results on 141 cases.

In this study we proposed to verify sensitivity and specificity of prostate-specific antigen (PSA), digital rectal examination (DRE) and transrectal ultrasound (TRUS) in patients who referred at our institution for prostatic complaints. 141 patients, ages ranging between 55 and 86 years (mean 67.5), underwent DRE, blood PSA, TRUS and ultrasonically guided biopsy of the prostate.